Why do you laff at me. I told you .25 cents would be support and where it was headed when the stock was in the .60 range and it got there.
Now its popped up some on a wing and prayer. Not even today's news has buyers interested. I see one trade for 250 shares...lol. Recent buying was probably folks who knew news was forthcoming.
Due to all the private placements at .25 cents --> the .25 number will be vigorously defended.
Numbers under .25 are less relevant, although there are clear support numbers below. BUT less relevant in that if .25 is broken then you're looking at an indication that insiders. et al, are giving up. If/when that happens there's no limit to how low it could possible go.
______________
This from the last 10k
For year ended December 31, 2017, our operations used approximately $3,062,000 in cash. This cash was provided primarily by cash on hand and net proceeds of $3,341,000 from equity issuances. At December 31, 2017, the Company had a cash balance of $1,271,000 and current assets less current liabilities of $953,000. We will need additional capital to maintain our operations, continue our research and development programs, conduct clinical trials, seek regulatory approvals and manufacture and market our products.
We will need to raise additional capital through the sale of our securities from time to time for the foreseeable future to fund the development of our drug product candidates through clinical development, manufacturing and commercialization. Our ability to obtain such additional capital will likely be subject to various factors, including our overall business performance and market conditions. If we cannot raise the additional funds required for our anticipated operations, we may be required to reduce the scope of or eliminate our research and development programs, delay our clinical trials and the ability to seek regulatory approvals, downsize our general and administrative infrastructure, or seek alternative measures to avoid insolvency. If we raise additional funds through future offerings of shares of our Common Stock or other securities, such offerings would cause dilution of current stockholders’ percentage ownership in the Company, which could be substantial. Future offerings also could have a material and adverse effect on the price of our Common Stock.
______________
Company is burning though a lot of cash [last year over $250k per quarter on avg] and will continue to do so for the foreseeable future. A buyout - like VTESSE had - is probably shareholders best hope
BWTFDIK?????????????
Good luck... hope you make a bundle.
